Funding Received
$39.7 Million in 9 Rounds from 5 Investors
Most Recent Funding
$14 Million on April 3, 2012 / Undisclosed Round
Headquarters:
Lebanon, NH
Description:
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.
Founders:
K. Dane Wittrup, Tillman Gerngross
Categories:
Biotechnology
Website:
http://www.adimab.com

Company Details

Update

Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Current Team (9)

Update

Funding Rounds (9) - $14M

Update

Board Members and Advisors (6)

Update

Investors (5)

Update
  • Yh0gzksfkd1eljis4wg8

    Google Ventures

    Google Ventures is the venture capital investment arm of Google Inc.
  • 833227dddcb31df78412232c4596d5ad

    SV Life Sciences

    Venture capital Firm
  • Aktht4eq1boptqctfosv

    Polaris Partners

    Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
  • B1ce9d2887c930e2d5d82b64a7eebcb9

    OrbiMed Advisors

    OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
  • 15f86da14352d2d2ee9ca9c7cb407a29

    Borealis Ventures

    Borealis Ventures partners closely with exceptional entrepreneurs from the earliest stages to...

Offices/Locations (1)

Update
  • Office

    16 Cavendish Court

    Lebanon, NH 03766

    USA